In addition, Affymetrix microarray analyses showed enhanced expression of PPAT, PAICS and PKM2 in poorly differentiated and stage 3 lung cancers (Supplementary Fig. S2A and S2B, respectively). This evidence concerns the gene PKM and lung carcinoma.